
--- Page 1 ---
FINAL DIAGNOSIS:  Part 1: Lymph node, Right sentinel #1, ExcisiOn -- One (1) Lymph noDe, negative for metastatic ADenocarcinoma (0/1). PArt 2: Lymph nODe, right Sentinel #2, EXcisiOn -  ONE (1).LYMPH NODE, POSITIVE FOR MICROMETASTASIS TWO (2) FOCI MEASURING LESS THAN 1.0 mm, AnD ONe (1) ALsO LEss THA 1.0 mm (1/1) (see comment). B. NO EXTRACAPSULAR SPREAD IS SEEN. Part 3: Lymph nOde, Right SentineL #3, EXcisiOn -- 1cs-0-3 ONE (1) LymPH NODE, NEGATIVE FOR METASTAT!C ADENOCARCINOMA (0/1). carcinoms, nifiltnstrug chuhd, nos 85os/3 Part 4: Lymph node, Right non-sentinel, ExcisiOn -- One (1) Lymph nODe, negative fOr metastatic Adenocarcinoma (0/1). Sit:brest Ns C50.9 3/1/u p Part 5: Breast, Right, segmental mastectomy - A.  infILtrating Ductai cArcinoma nOs *NOTTinghAm grade 1, ScOre Of 5/9 (tuBuleS = 2, nucLEI = 2, miTOsiS = 1). C. Tumor measures 2.0 cm on gross examination. D.  Ductal Carcinoma in-situ, cribriform type and with ComedO necrosis, nuclear grade 2. ADmIXeD wITh inVaSIve COmpOnent, COmprISiNg APprOXImateLy LeSs ThAn 5% Of The tOTAl TumOr VOLUmE. E.  SURGICAL MARGINS OF RESECTION ARE FREE OF INVASIVE TUMOR. F. CLOSEST POSTERIOR AnD SUPERiOR mARGInS OF RESECTION ARE AT 0.6 CM.E  mArgiNs Of resectiOn Are free Of Ductal CarcinOmA IN-SItU, CLOsest POsteriOr mArgIn C At 1.2 Cm. H. ANGIOLYMPHATIC INVASION IS IDENTIFIED. Estrogen receptor positive, progesterone receptor positive, her-2/neu negative (SCOre 0), per previous repORt SkiN WiTH nO SIgNIFiCAnt PaThOLUGIC ABNORmALITy. K. NOn-neOpLAsTic bReaSt witH FIBrocyStiC Changes, oUctAl epitheLial hypeRpLASiA, And FIBROADENOMATOID NODULES. Part 6: breast, Right medial new margin, eXcisiOn -- Breast tissue, negative for tumor. Part 7: breast, right Inferior new margin, excision - A.  fibroadipose tissue negative for tumor. FrAgMenTS OF SKeletaL muUSCLe. CASE SYNOPSIS:  SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST LATERALITY:  Right PROCEDURE: Segmental LOCATION: Not specified SIZE OF TUMOR:  Maximum dimension invasive component: 2.0 cm  MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: No TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS. NOTTIngham SCOre: Nuclear grade: 2 UUID:18E4043D-34BF-4CD1-9E2D-F906C7C78019 Tubule formation: 2 TCGA-BH-A0BT-01A-PR Redacted Mitotic activity score: 1 Total Nottingham score: 5 Nottingham grade (1, 2, 3): 1 ANGIOLYMPHATIC INVASION: Yes DERMAL LYMPHATIC INVASION: No CALCIFICATION:E No Tumor type, in situ: Cribriform DCIS admixed with invasive carcinoma Percent of tumor occupied by in situ component: 5 % SUrgICAl MArgINs iNVOLVED By inVASIvE COmpOnENT: No Distance of invasive tumor to closest margin: 6 mm Surg margins involved by in situ component: No Distance of in situ disease to closest margin: 12 mm LYMPH NODES POSITIVE: LYMPH NODES EXAMINED:  METHOD(S) OF LYMPH NODE EXAMINATION:  SentInel nOde metASTASiS:  H/E stain ONLy KERATIN POSITIVE CELLS ARE PRESENT: Yes SIZE OF NODAL METASTASES: No LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: Diameter of largest lymph node metastasis: 1 mm SKIN INVOLVED (ULCERATION): No NON-NEOPLASTIC BREAST TISSUE: FCD No t Stage, pathologic: N stage, pathologic: pT1c m Stage, pathologiC: pN1mi EstrOgen reCepTORS: pMX PROGESTEROnE RECEPTORS: positive positive HER2/NEU: zero or 1+